Skip to content

Transcatheter Arterial Micro-Embolization (TAME) using Nexsphere-F in Patients with Chronic Pain in Elbow or Wrist

A Single-arm, Single-center, Open-label, Pilot Clinical Study to Evaluate the Efficacy and Safety of Transcatheter Arterial Micro-Embolization (TAME) using Nexsphere-F in Patients with Chronic Pain in Elbow or Wrist

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0009270
Enrollment
38
Registered
2024-03-22
Start date
2023-12-06
Completion date
Unknown
Last updated
2024-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Since consent cannot be obtained during the procedure from subjects who meet the selection and exclusion criteria, written consent is obtained in advance between 4 weeks before the pr

Sponsors

Konkuk University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Those aged 19 to 80 2) Anyone who can provide a consent form 3) A person with a life expectancy of at least 12 months 4) Those who have not responded or failed in preservation treatment for at least three months (e.g. NSAIDS/physical therapy/steroidal joint injections, etc.) 5) Those with VAS Score of 4 or higher and Moderate-severe Elbow or Wrist Pain

Exclusion criteria

Exclusion criteria: 1) Those with a VAS Score of less than 4 and Mild Elbow or Wrist Pain 2) Chronic Renal Insufficiency (Serum creatinine > 2mg/dL) 3) Allergy to iodide contrast agents that do not respond to steroids 4) Those with acute infection or malignancy 5) Those who have previously had elbow or wrist surgery 6) Those with Bleeding Diabetes that cannot be calibrated

Design outcomes

Primary

MeasureTime frame
Percentage of subjects with a 50% or more reduction in QuickDASH Score

Secondary

MeasureTime frame
Rate of VAS Score;Rate of Changes in symptoms with QuickDASH Score;Rate of Changes in symptoms according to the Patient-Rated Tennis Elbow Evaluation (PRTEE) Score;The rate of reduction of medication and discontinuation rate of combination treatment

Countries

Korea, Republic of

Contacts

Public ContactJieun Jo

Konkuk University Medical Center

sierrazulu79@naver.com+82-2-2030-5523

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026